Fluciclovine (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Complete Title: Fluciclovine (FACBC) PET/CT Site-Directed Therapy of Oligometastatic Prostate Cancer (Flu-BLAST-PC)

Trial Phase: II

Investigator: Evan Yu

This phase II trial studies how well fluciclovine positron emission tomography (PET)/computed tomography (CT) improves long-term outcomes by facilitating early identification of metastatic prostate cancer amenable to both systemic and site-directed definitive therapy.

Keywords:

Prostate Cancer

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.